2015-2019年印第安人卫生服务署服务的美国印第安人和阿拉斯加原住民个体的糖尿病视网膜病变发病率和进展
这项回顾性队列研究分析了2015至2019年印第安人卫生服务署远程眼科项目中8374名糖尿病成人患者,评估无糖尿病视网膜病变(DR)或轻度非增殖性DR(NPDR)者的发病和进展。2015年无DR者中18.0%在2016至2019年出现轻度NPDR或更严重病变,发病率为每1000人年69.6例;轻度NPDR者中27.2%进展至中度NPDR或更严重。估计值低于既往报道,结果提示对部分患者可延长DR复查间隔。
要点
- 2015年无DR者中18.0%在2016至2019年出现轻度NPDR或更严重病变,0.1%出现增殖性DR。
- 无DR至任何DR的发病率为每1000人年69.6例,6.2%出现2级及以上进展。
- 2015年轻度NPDR者中27.2%进展至中度NPDR或更严重,2.3%出现2级及以上进展。
核心结论
- 该队列中DR发病率和进展估计值低于既往对美国印第安人和阿拉斯加原住民个体的报道。
- 结果提示,若随访依从性和视力结局不受影响,该人群中某些患者可延长DR复查间隔。
研究设计与样本
- 回顾性队列研究,纳入2015年有糖尿病且无DR证据或轻度NPDR、并在2016至2019年间至少复查1次的成人。
- 研究场所为印第安人卫生服务署(IHS)糖尿病眼病远程眼科项目,总队列8374人,平均(SD)年龄53.2(12.2)岁,2015年平均(SD)糖化血红蛋白8.3%(2.2%),女性4775人(57.0%)。
- 患者接受非散瞳超广角眼底成像(UWFI)或非散瞳眼底照相(NMFP)评估。
主要发现
- 2015年无DR的7097人中,18.0%(1280/7097)在2016至2019年出现轻度NPDR或更严重病变,0.1%(10/7097)出现增殖性DR(PDR)。
- 无DR至任何DR的发病率为每1000人年69.6例;6.2%(441/7097)从无DR进展至中度NPDR或更严重(即2级及以上进展),为每1000人年24.0例。
- 2015年轻度NPDR的1277人中,27.2%(347/1277)在2016至2019年进展至中度NPDR或更严重,2.3%(30/1277)进展至重度NPDR或更严重(即2级及以上进展)。
- 发病和进展与预期危险因素及采用UWFI评估相关。
临床怎么用
- 作者认为,若随访依从性和视力结局不受影响,该人群中某些患者可延长DR复查间隔。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Estimates of diabetic retinopathy (DR) incidence and progression in American Indian and Alaska Native individuals are based on data from before 1992 and may not be informative for strategizing resources and practice patterns. OBJECTIVE: To examine incidence and progression of DR in American Indian and Alaska Native individuals. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study conducted from January 1, 2015, to December 31, 2019, and included adults with diabetes and no evidence of DR or mild nonproliferative DR (NPDR) in 2015 who were reexamined at least 1 time during the 2016 to 2019 period. The study setting was the Indian Health Service (IHS) teleophthalmology program for diabetic eye disease. EXPOSURE: Development of new DR or worsening of mild NPDR in American Indian and Alaska Native individuals with diabetes. MAIN OUTCOMES AND MEASURES: Outcomes were any increase in DR, 2 or more (2+) step increases, and overall change in DR severity. Patients were evaluated with nonmydriatic ultra-widefield imaging (UWFI) or nonmydriatic fundus photography (NMFP). Standard risk factors were included. RESULTS: The total cohort of 8374 individuals had a mean (SD) age of 53.2 (12.2) years and a mean (SD) hemoglobin A1c level of 8.3% (2.2%) in 2015, and 4775 were female (57.0%). Of patients with no DR in 2015, 18.0% (1280 of 7097) had mild NPDR or worse in 2016 to 2019, and 0.1% (10 of 7097) had PDR. The incidence rate from no DR to any DR was 69.6 cases per 1000 person-years at risk. A total of 6.2% of participants (441 of 7097) progressed from no DR to moderate NPDR or worse (ie, 2+ step increase; 24.0 cases per 1000 person-years at risk). Of patients with mild NPDR in 2015, 27.2% (347 of 1277) progressed to moderate NPDR or worse in 2016 to 2019, and 2.3% (30 of 1277) progressed to severe NPDR or worse (ie, 2+ step progression). Incidence and progression were associated with expected risk factors and evaluation with UWFI. CONCLUSIONS AND RELEVANCE: In this cohort study, the estimates of DR incidence and progression were lower than those previously reported for American Indian and Alaska Native individuals. The results suggest extending the time between DR re-evaluations for certain patients in this population, if follow-up compliance and visual acuity outcomes are not jeopardized.
引用
- Fonda SJ, Bursell SE, Lewis DG, et al. Incidence and Progression of Diabetic Retinopathy in American Indian and Alaska Native Individuals Served by the Indian Health Service, 2015-2019. JAMA Ophthalmol. 2023. PMID: 36892822. doi:10.1001/jamaophthalmol.2023.0167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。